2008Chin J PancreatolRequires access

Effects of emodin on proliferation, apoptosis and expression of apoptotic regulating gene of human pancreatic cancer cell line BxPC3

Hui-tao Gao, Yusheng Liao, Xueke Fan, Cuifang Zhang, CHEN-Fen, Qiu Zhao

Open publisher page 0 citations

Abstract

Objective To investigate the effect of emodin on cell growth, proliferation cycle and its effect on the expression of apoptotic regulating gene of human pancreatic cancer cell line Bxpc-3 in vitro. Methods The survival rates of BxPC3 cell in vitro under the treatment of different concentrations emodin (0, 10, 20, 40, 80μmol/L) were detected by MTT colorimetric assay; the cell proliferation cycle and the apoptotic rate were examined with flow cytometry analysis; the expression of Bax, Bak, Bad and Bid mRNA was assessed by reverse transcriptase polymerase chain reaction (RT-PCR). Results (1) The inhibitory effort of emodin on BxPC3 cell proliferation was found to be in a dose-dependent manner along with the concentration of emodin changed from 0 μmol/L to 80 μmol/L, the cell survival rates were (97.42±2.45)%, (78.58± 3.11) %, (62.39±2.19) %, (51.68±2.92) %, (34.30±4.04)%; (2) Cell cycle changes were present in the groups treated with emodin, the percentage of cells in G0/G1 stage increased in a dose-dependent manner along with the concentration of emodin changed from 0 μmol/L to 80 μmol/L, the percentages of cells in G0/G1stage were (51.22±0.64)%, (53.88±0.72)%, (55.39±1.12)%, (58.17±1.48)%, (63.72± 1.52)%, and that in S stage decreased (42.87±0.67)%, (39.68±0.58)%, (34.60±1.06)%, (31.88± 1.48) %, (27.26±1.67)%; (3) The apoptotic rates of the groups treated with emodin raised in a dose-dependent manner, along with the concentration of emodin changed from 0 μmol/L to 80 μmoL/L, the cell apoptotic rates were (19.16±1.69)%, (31.78±2.21)%, (47.03±3.39)%, (55.92±5.39)%, (62.78± 3.19)%;(4)The expression of bax, bak, bad and Bid mRNA in BxPC3 cell treated with emodin was up-regulated significantly (F=55.649, P<0.01; F=19.403, P<0.05;F=29.009, P<0.05;F=39.546, P < 0.01). Conclusions Emodin was able to inhibit proliferation and induce the apoptosis of pancreatic cancer cell line BxPC3 effectively in vitro, and these effects were possibly associated with the up-regulation of bax, bak, bad and bid mRNA expression. Key words: Pancreatic neoplasms;  Emodin;  Apoptosis;  Cell cycle;  Apoptotic regulating gene

About this research paper

What this paper is about

Objective To investigate the effect of emodin on cell growth, proliferation cycle and its effect on the expression of apoptotic regulating gene of human pancreatic cancer cell line Bxpc-3 in vitro. Methods The survival rates of BxPC3 cell in vitro under the treatment of different concentrations emodin (0, 10, 20, 40, 80μmol/L) were detected by MTT colorimetric assay; the cell proliferation cycle and the apoptotic rate were examined with flow cytometry analysis; the expression of Bax, Bak, Bad and Bid mRNA was assessed by reverse transcriptase polymerase chain reaction (RT-PCR). Results (1) The inhibitory effort of emodin on BxPC3 cell proliferation was found to be in a dose-dependent manner along with the concentration of emodin changed from 0 μmol/L to 80 μmol/L, the cell survival rates were (97.42±2.45)%, (78.58± 3.11) %, (62.39±2.19) %, (51.68±2.92) %, (34.30±4.04)%; (2) Cell cycle changes were present in the groups treated with emodin, the percentage of cells in G0/G1 stage increased in a dose-dependent manner along with the concentration of emodin changed from 0 μmol/L to 80 μmol/L, the percentages of cells in G0/G1stage were (51.22±0.64)%, (53.88±0.72)%, (55.39±1.12)%, (58.17±1.48)%, (63.72± 1.52)%, and that in S stage decreased (42.87±0.67)%, (39.68±0.58)%, (34.60±1.06)%, (31.88± 1.48) %, (27.26±1.67)%; (3) The apoptotic rates of the groups treated with emodin raised in a dose-dependent manner, along with the concentration of emodin changed from 0 μmol/L to 80 μmoL/L, the cell apoptotic rates were (19.16±1.69)%, (31.78±2.21)%, (47.03±3.39)%, (55.92±5.39)%, (62.78± 3.19)%;(4)The expression of bax, bak, bad and Bid mRNA in BxPC3 cell treated with emodin was up-regulated significantly (F=55.649, P<0.01; F=19.403, P<0.05;F=29.009, P<0.05;F=39.546, P < 0.01). Conclusions Emodin was able to inhibit proliferation and induce the apoptosis of pancreatic cancer cell line BxPC3 effectively in vitro, and these effects were possibly associated with the up-regulation of bax, bak, bad and bid mRNA expression. Key words: Pancreatic neoplasms;  Emodin;  Apoptosis;  Cell cycle;  Apoptotic regulating gene

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the effect of emodin on cell growth, proliferation cycle and its effect on the expression of apoptotic regulating gene of human pancreatic cancer cell line Bxpc-3 in vitro. Methods The survival rates of BxPC3 cell in vitro under the treatment of different concentrations emodin (0, 10, 20, 40, 80μmol/L) were detected by MTT colorimetric assay; the cell proliferation cycle and the apoptotic rate were examined with flow cytometry analysis; the expression of Bax, Bak, Bad and Bid mRNA was assessed by reverse transcriptase polymerase chain reaction (RT-PCR). Results (1) The inhibitory effort of emodin on BxPC3 cell proliferation was found to be in a dose-dependent manner along with the concentration of emodin changed from 0 μmol/L to 80 μmol/L, the cell survival rates were (97.42±2.45)%, (78.58± 3.11) %, (62.39±2.19) %, (51.68±2.92) %, (34.30±4.04)%; (2) Cell cycle changes were present in the groups treated with emodin, the percentage of cells in G0/G1 stage increased in a dose-dependent manner along with the concentration of emodin changed from 0 μmol/L to 80 μmol/L, the percentages of cells in G0/G1stage were (51.22±0.64)%, (53.88±0.72)%, (55.39±1.12)%, (58.17±1.48)%, (63.72± 1.52)%, and that in S stage decreased (42.87±0.67)%, (39.68±0.58)%, (34.60±1.06)%, (31.88± 1.48) %, (27.26±1.67)%; (3) The apoptotic rates of the groups treated with emodin raised in a dose-dependent manner, along with the concentration of emodin changed from 0 μmol/L to 80 μmoL/L, the cell apoptotic rates were (19.16±1.69)%, (31.78±2.21)%, (47.03±3.39)%, (55.92±5.39)%, (62.78± 3.19)%;(4)The expression of bax, bak, bad and Bid mRNA in BxPC3 cell treated with emodin was up-regulated significantly (F=55.649, P<0.01; F=19.403, P<0.05;F=29.009, P<0.05;F=39.546, P < 0.01). Conclusions Emodin was able to inhibit proliferation and induce the apoptosis of pancreatic cancer cell line BxPC3 effectively in vitro, and these effects were possibly associated with the up-regulation of bax, bak, bad and bid mRNA expression. Key words: Pancreatic neoplasms;  Emodin;  Apoptosis;  Cell cycle;  Apoptotic regulating gene

Key concepts: Emodin, Apoptosis, Cell cycle, Flow cytometry, Cell growth, Molecular biology, MTT assay, Cell culture

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of emodin on proliferation, apoptosis and expression of apoptotic regulating gene of human pancreatic cancer cell line BxPC3 — Research Paper | ScholarLens